日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Socioeconomic disparities in long-term heart failure risk of trastuzumab with or without anthracyclines in early-stage breast cancer: a SEER-Medicare database analysis

早期乳腺癌患者接受曲妥珠单抗联合或不联合蒽环类药物治疗后,长期心力衰竭风险的社会经济差异:基于SEER-Medicare数据库的分析

Britten, Karissa; Lipsyc-Sharf, Marla; Yang, Eric H; McCloskey, Susan; Sedrak, Mina S; Teshome, Mediget; LaBarbera, Julia; Bardia, Aditya; McAndrew, Nicholas

CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential

CHD1L 在癌症及其他领域中的作用:结构、致癌功能和治疗潜力

Clune, Sophia; Awolade, Paul; Esquer, Hector; Zhou, Qiong; LaBarbera, Daniel V

Breast cancer cell coculture induces normal lung fibroblast transition to CAFs, promoting tumor cell dormancy and therapy resistance

乳腺癌细胞共培养可诱导正常肺成纤维细胞向癌相关成纤维细胞(CAFs)转化,从而促进肿瘤细胞休眠和治疗耐药性。

Klosowski, Marika L; Cronise, Kathryn E; Palmer, Eric P; McAuliffe, Kelly; Stratton, Claire; Sparks, Kelsie; Malmstrom, Kendall T; Knott-Byars, Gwyneth; Zhou, Qiong; Esquer, Hector; LaBarbera, Daniel V; Regan, Daniel P

Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer.

OTI-611 通过靶向抑制 CHD1L 来重编程化疗和靶向治疗诱导的细胞周期阻滞,并抑制增殖,从而在乳腺癌和结直肠癌中产生协同抗肿瘤作用

Esquer Hector, Zhou Qiong, LaBarbera Daniel V

EXTH-145. Chimeric Antigen Receptor-Engineered Extracellular Vesicles from Human Stem Cell-Derived Neutrophils for Glioblastoma Therapy

EXTH-145. 嵌合抗原受体工程化人干细胞来源中性粒细胞胞外囊泡用于胶质母细胞瘤治疗

Li, Linfeng; Zhou, Qiong; Voss, Ty C; Quick, Kevin L; LaBarbera, Daniel V; Michaelides, Loizos; Esmonde, Colin; Sun, Li; Chang, Yun; Zeng, Changchun; Quinones-Hinojosa, Alfredo; Xiaoping, Bao; Li, Yan

A mixed methods evaluation of well-being among incarcerated religious education participants in the United States

美国监狱宗教教育参与者幸福感的混合方法评估

LaBarbera, Robin

The validation of new CHD1L inhibitors as a therapeutic strategy for cancer

新型 CHD1L 抑制剂作为癌症治疗策略的验证

Sophia Clune, Paul Awolade, Qiong Zhou, Hector Esquer, Brock Matter, Jeffrey T Kearns, Timothy Kellett, Damilola Caleb Akintayo, Uday B Kompella, Daniel V LaBarbera

CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models

CHD1L 抑制剂 OTI-611 与化疗协同作用,增强抗肿瘤疗效并延长结直肠癌小鼠模型的生存期

Rita Sala, Hector Esquer, Timothy Kellett, Sophia Clune, Paul Awolade, Laura A Pike, Qiong Zhou, Wells A Messersmith, Daniel V LaBarbera

CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos

CHD1L 调节乳腺癌细胞存活,OTI-611 抑制该基因可阻碍 DNA 损伤反应并诱导 PARthanatos

Rita Sala, Hector Esquer, Timothy Kellett, Jeffrey T Kearns, Paul Awolade, Qiong Zhou, Daniel V LaBarbera

Validation of ferroptosis in canine cancer cells to enable comparative oncology and translational medicine

验证犬癌细胞中的铁死亡,以促进比较肿瘤学和转化医学的发展

Chatterji, Priya; Xing, Gang; Furst, Laura; Dave, Krishna; Zhou, Qiong; LaBarbera, Daniel V; Thamm, Douglas H; Eaton, John K; Wawer, Mathias J; Viswanathan, Vasanthi S